ShEEP Request for CTL ImmunoSpot S6 Universal Analyzer
ShEEP 请求 CTL ImmunoSpot S6 通用分析仪
基本信息
- 批准号:9795713
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-01 至 2019-09-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAntineoplastic AgentsAppointmentAreaArthritisB-LymphocytesBiological AssayCancer CenterCarcinomaCell CommunicationCellsCellular biologyChronicChronic DiseaseCitiesColorCommunitiesComplexCost of IllnessCytotoxic T-LymphocytesDefense MechanismsDegenerative polyarthritisDetectionDevelopmentDiseaseDisease ProgressionFlow CytometryFundingFutureGrantHealth SciencesHeart DiseasesHepatitisHeterogeneityImage AnalysisImmuneImmunologic MarkersImmunologic MonitoringImmunologicsImmunologyImmunooncologyInfectionInfiltrationInflammationInflammatoryInflammatory Bowel DiseasesInstitutionLeadershipMaintenanceMalignant NeoplasmsMalignant neoplasm of gastrointestinal tractMeasuresMediatingMedical centerMethodologyMicroscopicMinorMolecularMonitorNatureNon-Insulin-Dependent Diabetes MellitusObesityOklahomaPancreatitisPathologicPeer ReviewPerformancePeripheral Blood Mononuclear CellPlayPreventiveReaderResearchResearch ActivityResearch PersonnelResourcesRoleSample SizeScientistSheepSurveysT-LymphocyteTechnologyTimeTissuesUnited StatesUnited States National Institutes of HealthUniversitiesVeteransantigen-specific T cellsbasecareercell typecellular targetingcytokinedesigndrug developmentenzyme linked immunospot assayflexibilityinstrumentinterestmacrophageparticlepreventranpirnaseresearch facilitytooltumor
项目摘要
We are requesting funds to purchase a CTL ImmunoSpot® S6 Universal Analyzer. This instrument
allows investigators primarily to perform multi-color ELISPOT analysis along with other cell-
based applications. Currently, neither the research facility at the Oklahoma City VA Medical
Center (OKC VAMC) nor the affiliated University of Oklahoma Health Sciences Center has
this high-end ELISPOT analyzer. It is well known that immune cells play a critical role in many
diseases including cancer. It is now becoming evident that changes in immune cell heterogeneity
potentially impacts either positively or negatively on the disease progression. However, in the past
only limited technology allowed investigators to study heterogeneity of immune cells, immune
cells interaction with other cell types and their molecular impact in the tissue microenvironment
and more so, immunological markers interface in tissue microenvironment and systemically.
Immune monitoring is complex and better understanding requires multiplexing. CTL
ImmunoSpot® S6 Universal Analyzer permit multicolor T and B cell fluorospot analysis,
live/dead PBMC counting, and much more. This is an attractive alternative to flow cytometry
analysis. CTL ImmunoSpot® S6 Universal Analyzer also allows investigators for other
applications at the microscopic (single cells and subcellular particles) as well as the macroscopic
level (colonies and Plaques). The primary field of application for CTL ImmunoSpot® S6 Universal
Analyzer has been multi-color ELISPOT analysis. CTL employs a technology specifically
designed to avoid excitation cross-contamination, enabling the accurate detection of up to eight
analyte co-expressing cells, including polyfunctional T cells. In addition, image analysis-based
multi-parameter analysis of cells with CTL ImmunoSpot® S6 Universal Analyzer can be useful
with both adherent or non-adherent cells alike, and the sample size for analysis can be as low as
one cell.
A survey of all VA researchers at OKC VAMC showed over 80% of the researchers are potentially
interested to use CTL ImmunoSpot® S6 Universal Analyzer to study the modulation of antigen-
specific T cell induction and activation in their research. This instrument will be used by six major
users who have VA Merit grants funded or pending. We also anticipate that researchers at other
VA centers will use this instrument.
我们要求资金购买CTLImmunoSpot®S6通用分析仪。这个乐器
允许研究人员主要可以进行多色ELISPOT分析以及其他细胞
基于应用程序。目前,俄克拉荷马城弗吉尼亚州医疗的研究机构均未
中心(OKC VAMC)或俄克拉荷马州会员大学健康科学中心已有
这款高端ELISPOT分析仪。众所周知,免疫细胞在许多人中起着至关重要的作用
包括癌症在内的疾病。现在正在证明免疫电池异质性的变化
可能对疾病进展产生积极或负面影响。但是,过去
只有有限的技术才允许研究人员研究免疫细胞的异质性,免疫
细胞与其他细胞类型的相互作用及其在组织微环境中的分子影响
更重要的是,在组织微环境和系统中的免疫标记物接口。
免疫监测是复杂的,更好的理解需要多路复用。 CTL
Immunospot®S6通用分析仪允许多色T和B细胞荧光组分析,
活/死PBMC计数等等。这是流式细胞仪的有吸引力的替代方法
分析。 CTLImmunospot®S6通用分析仪还允许研究人员
在微观(单细胞和亚细胞颗粒)以及宏观上的应用
水平(殖民地和斑块)。 CTLImmunospot®S6通用申请的主要领域
分析仪是多色ELISPOT分析。 CTL员工专门
旨在避免兴奋的交叉污染,可准确检测多达八个
分析物共表达细胞,包括多功能T细胞。此外,基于图像分析
用CTLImmunospot®S6通用分析仪对细胞的多参数分析可以有用
使用粘附或非粘附细胞,以及用于分析的样本量
一个单元。
OKC VAMC的所有VA研究人员的调查显示了超过80%的研究人员
有兴趣使用CTLImmunoSpot®S6通用分析仪研究抗原的调节
特定的T细胞诱导和研究中的激活。该乐器将由六个专业使用
拥有VA功绩赠款的用户资助或待处理。我们还期望其他研究人员在其他
VA中心将使用此工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chinthalapally V. Rao其他文献
Targeting PGE<sub>2</sub>/IL-23 Nexus in TME for CRC Prevention and Treatment
- DOI:
10.1016/j.canlet.2023.216553 - 发表时间:
2024-01-28 - 期刊:
- 影响因子:
- 作者:
Chinthalapally V. Rao - 通讯作者:
Chinthalapally V. Rao
Chinthalapally V. Rao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chinthalapally V. Rao', 18)}}的其他基金
PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND ENDPOINT BIOMARKERS. TASK ORDER TITLE: URINARY BLADDER CANCER PREVENTIO
预防癌症临床前药物开发计划:临床前疗效和终点生物标志物。
- 批准号:
10269136 - 财政年份:2020
- 资助金额:
-- - 项目类别:
EVALUATION OF TWO DIFFERENT CLASSES OF COMPOUNDS (STAT3 INHIBITORS AND SERMS) FOR THE PREVENTION OF URINARY BLADDER CANCER.
评估两类不同类型的化合物(STAT3 抑制剂和 Serms)预防膀胱癌的作用。
- 批准号:
10674662 - 财政年份:2020
- 资助金额:
-- - 项目类别:
EVALUATION OF TWO DIFFERENT CLASSES OF COMPOUNDS (STAT3 INHIBITORS AND SERMS) FOR THE PREVENTION OF URINARY BLADDER CANCER.
评估两类不同类型的化合物(STAT3 抑制剂和 Serms)预防膀胱癌的作用。
- 批准号:
10269139 - 财政年份:2020
- 资助金额:
-- - 项目类别:
PREVENTION OF CRC BY iNOS AND COX-2 SELECTIVE INHIBITORS
通过 iNOS 和 COX-2 选择性抑制剂预防 CRC
- 批准号:
6815750 - 财政年份:2004
- 资助金额:
-- - 项目类别:
PREVENTION OF CRC BY iNOS AND COX-2 SELECTIVE INHIBITORS
通过 iNOS 和 COX-2 选择性抑制剂预防 CRC
- 批准号:
6952292 - 财政年份:2004
- 资助金额:
-- - 项目类别:
相似国自然基金
SVCI疾病进展中多尺度脑结构-功能耦合演变规律的研究
- 批准号:82302142
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型电化学发光传感体系及其用于感染性疾病多指征监测的研究
- 批准号:82373831
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
纤溶酶原结合蛋白Tetranectin通过抑制梭形菌的肠道内定植介导肠黏膜炎症相关疾病发展的机制研究
- 批准号:82370540
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
左心内皮细胞Piezo1激活EDN1/HIF通路诱导左心疾病所致肺动脉高压的机制研究
- 批准号:82300067
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于睡眠期间血氧饱和度探讨室内超细颗粒物短期暴露与慢性阻塞性肺疾病患者心肺健康的关联及其机制
- 批准号:22376005
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
2023 Polyamines Gordon Research Conference and Gordon Research Seminar
2023年多胺戈登研究会议暨戈登研究研讨会
- 批准号:
10675969 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Neural Circuits, Kinetics and Energetics HTS of Human iPSC-Neurons, -Microglia, and -Astrocytes: AI-Enabled Platform for Target ID, and Drug Discovery and Toxicity (e.g., Cancer Chemo & HIV ARTs)
人类 iPSC 神经元、小胶质细胞和星形胶质细胞的神经回路、动力学和能量 HTS:用于目标 ID、药物发现和毒性(例如癌症化疗)的 AI 平台
- 批准号:
10707866 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Baboon model of chemotherapy-related cognitive impairment and accelerated aging
化疗相关认知障碍和加速衰老的狒狒模型
- 批准号:
10505742 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Baboon model of chemotherapy-related cognitive impairment and accelerated aging
化疗相关认知障碍和加速衰老的狒狒模型
- 批准号:
10677750 - 财政年份:2022
- 资助金额:
-- - 项目类别:
MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients
MCLENA-1:评估来那度胺在遗忘性 MCI 患者中的临床试验
- 批准号:
10630526 - 财政年份:2022
- 资助金额:
-- - 项目类别: